cp 46665 has been researched along with Ovarian Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Berens, ME; Modest, EJ; Noseda, A; White, JG | 1 |
1 other study(ies) available for cp 46665 and Ovarian Neoplasms
Article | Year |
---|---|
In vitro antiproliferative activity of combinations of ether lipid analogues and DNA-interactive agents against human tumor cells.
Topics: Adenocarcinoma; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cell Division; Cell Survival; Cisplatin; Cyclophosphamide; Doxorubicin; Female; In Vitro Techniques; Ovarian Neoplasms; Phospholipid Ethers; Piperidines; Tumor Cells, Cultured | 1988 |